Mindfulness Intervention for Emotional Distress (MIED) in Patients With GERD
NCT07667894 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2026-06-25
Summary
The goal of this multicenter randomized waitlist-controlled clinical trial is to evaluate whether an online Mindfulness-Based Intervention for Emotional Distress (MIED) can reduce emotional distress and reflux-related symptoms in adults with gastroesophageal reflux disease (GERD). GERD is a common chronic gastrointestinal condition that is frequently accompanied by anxiety, depressive symptoms, stress, and impaired quality of life.
The main questions this study aims to answer are:
Can online MIED reduce emotional distress in patients with GERD?
Can online MIED reduce reflux-related symptoms and improve reflux-related quality of life?
Are changes in psychological processes, such as distress tolerance, cognitive flexibility, experiential avoidance, emotional behaviors, and life engagement, associated with improvements in emotional distress and reflux symptoms?
Researchers will compare participants receiving online MIED with participants in a waitlist control group receiving usual medical care and health management to determine whether online MIED leads to greater improvement over time.
Participants will:
complete screening and baseline assessments;
be randomly assigned to either the online MIED intervention group or the waitlist control group;
if assigned to the intervention group, complete an 8-week online MIED program with one session per week;
continue necessary usual medical care during the study, while keeping medication use stable when possible;
complete online questionnaires at baseline, during the intervention, after the intervention, and at 3, 6, 12, and 24 months after the intervention;
report information on reflux symptoms, emotional distress, quality of life, sleep, stress, resilience, life satisfaction, healthcare use, intervention adherence, and adverse events.
Conditions
- Gastroesophageal Reflux Disease
- Emotional Distress
Interventions
- OTHER
-
TAU
Participants will continue usual GERD treatment and health management during the 49-day observation period. They will not receive MIED, mindfulness training, or other structured psychological interventions during this period. Usual care may include medication, lifestyle advice, and necessary follow-up as determined by clinicians. The waitlist control group will complete assessments at the same time points as the MIED group. After the 2-year follow-up, participants in the waitlist control group who wish to receive the program will be offered the same MIED course.
- OTHER
-
MIED
The intervention is delivered via the internet and is grounded in the psychopathological diamond model of emotional distress proposed by Liu and colleagues. The program is supported by a MIED knowledge base, the Mindfulness Study public account, supervision and question-answer records, and official materials from Liu Xinghua and the MIED team. These resources are integrated into a WeChat self-help mini-program and the MIED Mindfulness Assistant, an artificial intelligence-supported system developed using large language models such as Tencent Hunyuan and DeepSeek R1. Together, these tools support participants' learning and practice over a continuous 49-day training period.
Sponsors & Collaborators
-
Xinghua Liu
lead OTHER
Principal Investigators
-
Xinghua Liu, Dr. · Peking University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-07-01
- Primary Completion
- 2028-05-15
- Completion
- 2028-05-15
Countries
- China
Study Locations
More Related Trials
-
Cognitive-behavioral Therapy for the Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.
NCT06939465 ·Status: RECRUITING ·Phase: NA
-
Transcutaneous Electrical Acustimulation (TEA) for the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)
NCT07572708 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Outcomes for Patients With Gastro-Esophageal Reflux Disease
NCT03824548 ·Status: UNKNOWN
-
Gastroesophageal Reflux Disease Diagnostic Trial
NCT06504134 ·Status: NOT_YET_RECRUITING
-
The Effect of PPI in Preventing Gastroesophageal Reflux Disease of Seafarers
NCT04696783 ·Status: UNKNOWN ·Phase: PHASE3
-
Targeting Hypervigilance and Autonomic Arousal: the Psycho-physiologic Model of Gastroesophageal Reflux Disease (GERD)
NCT04960566 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Mobile Application for Gastroesophageal Reflux Disease
NCT07744815 ·Status: COMPLETED ·Phase: NA
-
Important Correlation Between Anxiety and Reflux Symptoms in Patients With Gastroesophageal Reflux Disease
NCT06151067 ·Status: COMPLETED
-
Developing and Testing Mobile Health Question Prompt List in Gastroesophageal Reflux Disease
NCT05900687 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Structured Treatment of Gastroesophageal Reflux in a Company Health Care Setting, -Effect on Quality of Life, Symptoms and Productivity
NCT00884247 ·Status: COMPLETED
-
Prevalence of GERD, Its Effect on HRQL and Psychological Disturbance, and the Effect of Eating Behaviors on GERD Prevalence
NCT07164274 ·Status: COMPLETED
-
the Efficency and Safety of Stretta in GERD
NCT03574831 ·Status: UNKNOWN
-
Evaluating Medication Adherence of Patients With Gastroesophageal Reflux Disease With Support of Smartphone Application GERDCare
NCT07127276 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy of Traditional Chinese Medicine Combined With Omeprazole in Patients With Non-erosive Reflux Disease
NCT02892357 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Safety and Effectiveness of eGERD Device to Reduce Gastroesophageal Reflux Disease (GERD) Symptoms
NCT06613438 ·Status: RECRUITING ·Phase: NA
-
The Effect of Positional Therapy on Symptoms of Gastroesophageal Reflux Disease: A Prospective Pilot Study
NCT04500288 ·Status: UNKNOWN ·Phase: NA
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Gastroesophageal Reflux Disease Among College Students
NCT04034017 ·Status: COMPLETED
-
Radiofrequency Energy Delivery for Gastroesophageal Reflux Disease
NCT03223116 ·Status: UNKNOWN ·Phase: NA
-
Understanding the Pathophysiology and Effects of Diaphragmatic Breathing in Upright Gastroesophageal Reflux
NCT02972047 ·Status: COMPLETED ·Phase: NA
-
A Comparison of Factors of Symptoms Generation and Evaluation of Role of Biofeedback in Patients With Different Types of Functional Esophageal Disorders (Functional Heartburn and Functional Chest Pain)
NCT00471796 ·Status: UNKNOWN ·Phase: NA
-
The Potential Therapeutic Effect of Melatonin in Gastro-Esophageal Reflux Disease
NCT00915616 ·Status: WITHDRAWN ·Phase: PHASE3
-
Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease
NCT06984484 ·Status: RECRUITING ·Phase: NA
-
Correlates of GERD Symptom Severity
NCT03020550 ·Status: COMPLETED
-
Endoscopic Treatment of Gastroesophageal Reflux Disease
NCT05678491 ·Status: ENROLLING_BY_INVITATION ·Phase: NA